Does Rallies show Form 4 insider transactions for INBS?

Yes. Rallies tracks INBS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is INBS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for INBS. It does not provide personalized investment advice.

INBS (Intelligent Bio Solutions Inc. Common Stock) Stock Analysis - Insider Trades

Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of May 21, 2026, INBS trades at $2.83 with a market cap of $8.73M and a P/E ratio of 0.34. INBS moved -11.85% today. Year to date, INBS is -74.27%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.27 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading INBS stock inside the company?

Recent INBS insider activity includes Simeonidis Harry bought 50 and Simeonidis Harry bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.

INBS Key Metrics

Key financial metrics for INBS
Metric	Value
Price	$2.83
Market Cap	$8.73M
P/E Ratio	0.34
EPS	$8.95
Dividend Yield	0.00%
52-Week High	$27.50
52-Week Low	$2.27
Volume	0
Avg Volume	0
Revenue (TTM)	$3.91M
Net Income	$-11.65M
Gross Margin	47.25%

Recent INBS Insider Trades

Simeonidis Harry bought 50 (~$92.5) on Sep 1, 2023.
Simeonidis Harry bought 100 (~$192) on Aug 31, 2023.

Latest INBS News

Q3 Revenue Up 46% to $1.06M as Margins Exceed 50% — May 13, 2026
Intelligent Bio Solutions Launches Study to Achieve Sub-3-Minute Drug Screening — Apr 20, 2026
Intelligent Bio Solutions Validates Security with Zero Vulnerabilities Ahead of FDA 510(k) Bid — Apr 17, 2026
Intelligent Bio Solutions Completes Codeine Detection Study in 40 Adults, Advances FDA 510(k) Program — Apr 2, 2026
Intelligent Bio Solutions Secures Eighth European Patent for Volume-Corrected Fingerprint Testing — Mar 26, 2026

INBS Analyst Consensus

INBS analyst coverage data. Average price target: $0.00.

Common questions about INBS

Who is trading INBS stock inside the company?: Recent INBS insider activity includes Simeonidis Harry bought 50 and Simeonidis Harry bought 100. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for INBS?: Yes. Rallies tracks INBS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is INBS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for INBS. It does not provide personalized investment advice.